INTRODUCTION
The intestinal epithelium is maintained by intestinal stem cells (ISCs) , which reside at the bottom of the crypt (Okamoto and Watanabe, 2016) . ISCs are identified by the expression of specific genes, such as leucine-rich repeatcontaining G-protein-coupled receptor 5 (Lgr5) (Barker et al., 2007) . The differentiation of intestinal epithelial cells (IECs) predominantly proceeds in a unidirectional manner, starting from the ISCs to the terminally differentiated cells. In the earliest phase of this process, progenitor cells are committed either to a secretory or absorptive lineage based on the expression of key transcription factors such as atonal homolog-1 (ATOH1) or hairy and enhancer of split-1 (HES1) (Jensen et al., 2000; Yang et al., 2001) .
However, a recent study showed that small-intestinal IECs committed to the absorptive lineage can exhibit ISCoriented de-differentiation upon severe epithelial damage (Tetteh et al., 2016) . Other studies have further highlighted the plasticity and ISC-oriented de-differentiation of secretory lineage-committed IECs in the small intestine, which are identified by the expression of NGN3 (Schonhoff et al., 2004) , Delta-like 1 (DLL1) , and doublecortin-like kinase 1 (DCLK1) (Westphalen et al., 2014) . ATOH1 + label-retaining cells (LRCs) reside at the +4 position and serve as secretory progenitor cells, but they can also exhibit ISC properties upon severe tissue injury (Buczacki et al., 2013) . These studies indicated that a collective proportion of ATOH1 + secretory lineagecommitted IECs retain their potential to revert to ISCs and can exhibit ISC-specific properties upon severe tissue injury to compensate for the massive loss of genuine ISCs (Mills and Sansom, 2015) . Consistent with this finding, a recent single-cell analysis of LGR5 + IECs identified the rare presence of ATOH1 + LGR5 + double-positive cells in normal small-intestinal crypts (Kim et al., 2016) . However, the comprehensive and dynamic contributions of these ATOH1 + potential ISCs under normal and pathologic
conditions have yet to be described. In addition, the key factors that can recruit a specific subset of ATOH1 + IECs back to the ISC pool upon severe epithelial damage remain mostly uncertain. In intestinal tumorigenesis, several studies have shown that LGR5 + ISCs are the cells of origin of sporadic adenomatous polyposis coli (Apc)-deficient tumors (bottom-up model) (Barker et al., 2009) . Other studies have shown that villus cells can initiate tumor development through overexpression of GREM1 or constitutive activation of the nuclear factor kappa-B (NF-kB) pathway (Davis et al., 2015; Schwitalla et al., 2013) . These studies raise the possibility that de-differentiation of lineage-committed IECs may constitute another pathway of intestinal Figure 1 . Establishment of ATOH1 + Cell-Lineage Tracing (A) Schematic representation of the alleles used to establish the Atoh1 tdTomato mice. (B) Co-staining of ATOH1 (green) and tdTomato (red) in small-intestinal and colonic tissues. Atoh1 tdTomato mice were administered RU486 in either a single dose (single dose) or for 5 consecutive days (five-dose) and were then analyzed on the day following the final treatment. Note that all of the tdTomato + IECs co-expressed ATOH1.
(legend continued on next page) tumorigenesis (top-down model). Accordingly, inflammatory bowel disease (IBD) patients develop colitis-associated cancers (CACs) via a pathway distinct from that of sporadic colon cancers. Established CACs are abundant in Atoh1 + cells and, thus, retain features of secretory lineage-committed cells, such as mucin production (Park et al., 2006) . The robust expression of ATOH1 in CACs may be supported by environmental tumor necrosis factor alpha (TNF-a) and contributes to maintaining their highly malignant properties (Fukushima et al., 2015) . However, the potential contribution of ATOH1 + secretory lineagecommitted IECs as the origin of CAC tumor stem cells has yet to be described. In this study, using the ATOH1 + cell-lineage-tracing model, we showed that colonic ATOH1 + IECs could give rise to functional ISCs under both homeostatic and pathologic conditions. The results highlight the unexpectedly broad contribution of ATOH1 + IEC-derived ISCs to the maintenance, regeneration, and progression of colitisassociated tumorigenesis in the colonic epithelium.
RESULTS

Lineage Tracing of ATOH1 + IECs Labels Secretory Lineage IECs
To elucidate the dynamic contribution of ATOH1 + IECs to the maintenance of the intestinal epithelium, we planned a lineage-tracing experiment. Here, we crossed Atoh1
Cre-PGR mice (Rose et al., 2009 ) with Rosa26-LSL-tdTomato reporter mice to generate Atoh1
Cre-PGR ; Rosa26-LSL-tdTomato mice (Atoh1 tdTomato mice, Figure 1A ). In these mice, the effect of haploinsufficiency due to the knockin allele could not be observed, as confirmed through the analysis of Atoh1 mRNA and protein expression in the small intestine and colon (Figures S1A-S1C). To optimize the RU486-mediated tdTomato labeling of ATOH1 + IECs, we compared the labeling efficiency between a single dose of RU486 and the injection of RU486 for 5 consecutive days. Both protocols successfully labeled ATOH1 + IECs in the crypts of the small intestine and colon ( Figure 1B ). The 5-dose protocol resulted in a higher labeling efficiency ( Figure 1C ) and was therefore employed in the majority of the following experiments.
The analysis performed 24 hr after a single dose of RU486 showed that all secretory lineage IECs and some Ki-67 + IECs were initially labeled by tdTomato ( Figures 1D and  1E) . Conversely, all of the tdTomato + IECs were completely negative for HES1 ( Figure S1D ) and for other absorptive lineage markers ( Figure S1E ). To further confirm the labeling of mitotic IECs, the uptake of 5-ethynyl-2 0 -deoxyuridine (EdU) was examined in ATOH1 + IECs. Using CD24 as a marker for lower crypt IECs ( Figure 1F ) , we found that 4.7% of the CD24 high/mid tdTomato + IECs were also positive for EdU ( Figure 1G ). These results collectively confirmed that our ATOH1 + IEC lineage-tracing system initially labeled both postmitotic and mitotic secretory lineage-committed IECs in a highly specific manner. Figure 2B ). Consistently, RNAscope in situ hybridization (RNAscope ISH) clearly exhibited Lgr5 + Atoh1 + doublepositive cells, most frequently at the +4 position or +3 position of the small intestine and colon, respectively ( Figure 2C ). The integrity of our RNAscope analysis was validated by using positive control tissues (Figures S2A and S2B) . Also, tdTomato + crypt cells co-expressing Ascl2 were found in both regions ( Figure 2D ). CD24 is commonly expressed by small-intestinal and colonic crypt IECs ( Figure 1F) Figure S1 . Figure 2F ). qRT-PCR analysis of these cell populations showed that gene markers for secretory cell progenitors (Dll1) and genes recently identified as markers of LRCs (Nfatc3, Nfat5) (Buczacki et al., 2013) were highly expressed in the CD24 high/mid tdTomato + IECs ( Figure 2G ).
Atoh1
Exceptionally, CD82 showed highest expression in CD24 Figure 2H ). However, expression of these genes was also detected in the CD24 high/mid tdTomato + IEC population, although at a much lower level. These results sufficiently indicated that ATOH1 + IECs in the normal intestinal epithelium consist of a heterogeneous cell population, including secretory lineage progenitor cells, and a small population of IECs retaining ISC-specific gene expression. Figure 3I ). These results confirmed that a specific population of ATOH1 + IECs is constitutively re-directed to exhibit genuine ISC-specific properties and participate in the maintenance of the normal intestinal epithelium.
Colonic Inflammation Promotes the Generation of ATOH1 + IEC-Derived Clonal Ribbons
Following epithelial injury, various signaling pathways are activated within the intestinal epithelium to aid in optimization of the regeneration program . In the present study, only a minimal increase in the number of small-intestinal ATOH1 + ICRs was observed following irradiation-induced damage (control group, 0.20 ribbons per 1,000 crypts; irradiation group, 0.63 ribbons per 1,000 crypts; data not shown). Thus, we examined whether the recruitment of colonic ATOH1 + IECs to the ISC pool and the subsequent formation of ATOH1 + ICRs could be enhanced in a dextran sodium sulfate (DSS) colitis model. A significant reduction in body weight in the DSS-colitis mice indicated the successful induction of colitis ( Figure S4A ). At day 2, we found only a small number of tdTomato + IECs in the rectum of DSS-colitis mice (Figure S4B) . However, at day 6, we found clear increase in the number of tdTomato + IECs in DSS-colitis mice ( Figure 4B ).
At this time period, LGR5
+ ATOH1 + double-positive cells
were not clearly identified in the rectal crypts of DSS-colitis mice ( Figure 4C ). However, a clear and persistent existence of ATOH1 + IECs was observed in the rectum of these DSS-colitis mice ( Figures S4C and S4D ). Accordingly, a significant increase in the mucosal area occupied by tdTomato + IECs was observed during the recovery phase (day 6, day 13, and day 20) of the damaged mucosa ( Figures  S4E and S4F) . Importantly, ATOH1 + ICRs appeared in the rectum of DSS-colitis mice as early as day 6, a time period when they were never observed in the control mice. Some of the massive tdTomato + area in the DSS-colitis mice at day 13 represented a cluster of tdTomato + IECs extending from the ulcer-edge crypts, which covered the surface of the adjacent wound ( Figure 4D ). This observation indicated that ATOH1 + IEC progenies actively contribute to the early phase of tissue repair by forming the wound-associated Atoh1 tdTomato mice on day 20 compared with the data on day 6 shown in Figure 2B . (I) Designated cell fractions in (H) were subjected to microarray analysis and then compared and analyzed for the adult stem cell-specific gene set (M1999) by GSEA. See also Figure S3 . (legend continued on next page) epithelium (Seno et al., 2009 was significantly promoted at the earliest phase of the tissue repair process in DSS-colitis mice, and thereby partly contributed to the regeneration of colitis-associated wounds.
Inflammatory Cytokines and Bacterial Components
Coordinately Promote the Formation of ATOH1 + ICRs To obtain insight into the mechanism underlying the promotion of ATOH1 + ICR formation in the colitic environment, the tdTomato + IEC population in the rectum of DSScolitis-induced Atoh1 tdTomato mice was collected ( Figure 5A) and subjected to microarray analysis. MA plot analysis identified Dll1 as one of the highly upregulated genes in the tdTomato + IEC population of the DSS-colitis mice (Fig- ure 5B). Consistently, a clear increase in the number of DLL1 + tdTomato + double-positive IECs was confirmed in the rectal tissue of the DSS-colitis mice ( Figure 5C ). Pathway analysis of the microarray data additionally revealed that gene sets representing the general inflammatory response were most significantly upregulated. Furthermore, we found that the response to interleukin (IL)-1 and TNF-a was significantly upregulated in the ATOH1 + IECs of the DSS-colitis mice ( Figure S5A ). The NF-kB pathway represents the major downstream signaling pathway shared by TNF-a and IL-1b (Mercurio and Manning, 1999) . A previous study highlighted the importance of constitutive NF-kB pathway activation in the de-differentiation of mouse small-intestinal villus IECs (Schwitalla et al., 2013) . Our GSEA consistently revealed that the NF-kB pathway gene set was significantly upregulated in the tdTomato + IECs of the DSS-colitis mice ( Figure 5D ), as were genes related to stem cell maintenance ( Figure 5E ). Thus, in DSS colitis, ATOH1 + IEC-derived cells appeared to gain stem cell-like gene expression under an increased activation level of the NF-kB pathway.
To validate the contribution of NF-kB signaling to ATOH1 + ICR formation, we performed in vitro analyses using organoid culture. Colonic organoids from Atoh1 tdTomato mice were cultured under DBZ-induced differentiation conditions, which clearly promoted commitment to the ATOH1 + secretory cell lineage, and also promoted downregulation of ISC-specific genes ( Figure S5B ). To induce activation of the NF-kB pathway, two representative bacterial components, such as lipopolysaccharide (LPS) and flagellin, were employed in addition to TNF-a and IL-1b. The combined addition of these ligands (TILF cocktail) clearly upregulated the expression of IL-8 in DBZ-treated colonic organoids ( Figure S5C ) and induced the degradation of IkBa ( Figure S5D ), which confirmed the activation of the NF-kB pathway in secretory cell-committed organoids. Using these secretory cell-committed organoids, we proved that addition of the TILF cocktail could induce the formation of colonic ATOH1 + ICRs in vitro ( Figures 5F and 5G ). This in vitro formation of ATOH1 + ICRs in secretory cellcommitted organoids clearly required the addition of all ligands ( Figure 5H ). Specific blockade of the NF-kB pathway using small-molecule compounds ( Figure S5E ) consistently inhibited the formation of ATOH1 + ICRs in a dose-dependent manner ( Figures 5I and S5F) . Thus, we found that the NF-kB pathway functions as a key pathway in promoting the exhibition of ISC properties by ATOH1 + IEC-derived cells. Accordingly, the addition of TILF ligands clearly upregulated the expression of ISC markers Ascl2 and Smoc2, in addition to Dll1 (Figure 5J ), suggesting that the expression of these genes may play a key role in the inflammation-induced formation of ATOH1 + ICRs. Such a TILF-cocktail-induced upregulation of ISC markers was never observed in organoids treated without DBZ (Figure S5G ). However, the expression level of Lgr5 remained unchanged both in DBZ-treated and untreated organoids ( Figures 5I and S5G) , possibly due to its low expression level in early reprogrammed ISCs.
To validate the ISC property of TILF-treated Atoh1 + IECderived cells in vitro, we tested whether TILF-treated + ICR formation frequency in the rectum of DSS-colitis mice (n = 3) and control mice (n = 3). The number of ATOH1 + ICR was normalized by the total number of crypts. Data are expressed as the mean ± SEM per 1,000 crypts. *p < 0.0001. See also Figure S4 . single isolated cells ( Figure 5K) . Also, an increased number of tdTomato + organoids was re-constructed from single isolated IECs that were recovered from the DSS-colitis mice ( Figures 5L and 5M ), indicating enrichment of cells retaining ISC-like properties.
ATOH1 + IECs Comprise Colitis-Associated Tumors and
Acquire Tumor Stem Cell Properties CAC develops through a pathway distinct from that of sporadic colon cancer (Feagins et al., 2009; Thorsteinsdottir et al., 2011) and shows pathologic features such as high ATOH1 expression (Kano et al., 2013; Park et al., 2006) . However, the precise role of ATOH1 + IECs in CACs remains uncertain. We have previously shown that TNF-a mediated activation of the NF-kB pathway in IECs plays an indispensable role in azoxymethane (AOM)-DSS tumor formation in mice (Onizawa et al., 2009 ). Hence, we asked whether the tumors of AOM-DSS model mice (Parang et al., 2016) harbor ATOH1 + tumor cells and exhibit features of CACs ( Figure 6A ). It was found that AOM-DSS tumors contained a substantial number of ATOH1 + tumor cells and expressed ATOH1 at a high level ( Figures S6A-S6C ). Furthermore, increased production of mucin was observed in these tumors ( Figure S6D ), suggesting that they faithfully phenocopy CACs.
At the early stage of AOM-DSS tumor labeling in Atoh1 tdTomato mice, only a few isolated tdTomato + tumor cells were found (day 56, Figure 6B ). However, clear expansion of the tdTomato + area within the tumor was observed after day 70, which represented a continuous cluster of tdTomato + tumor cells ( Figures 6C and 6D ).
The ratio of these tumor ATOH1 + ICRs among tumorforming ducts did not increase during the tumor development ( Figure 6D ), but they clearly included Ki-67 + cells
and ATOH1 + cells and showed nuclear translocation of b-catenin ( Figure 6E ). In contrast, they lacked expression of secretory cell markers other than MUC2 ( Figure S6E) . Importantly, some of the tdTomato + cells co-expressed tumor stem cell markers such as CD44 or CD133 (Zeilstra et al., 2008; Zhu et al., 2009 ) ( Figure S6F ). Moreover, Lgr5 ICR was normalized by the total organoids that were established during the experimental period. The presented data are from three independent analyses including over 100 organoids from each experimental condition. Data are expressed as the mean ± SEM. *p < 0.05. (I) Quantitative analysis of the in vitro lineage-tracing analysis. Data are expressed as the mean ± SEM (three independent analyses). *p < 0.05. Piceatannol or IMD0354 was added at the same time as the TILF cocktail. (J) qPCR analysis of colonic organoids. Data are expressed as the mean ± SEM of values normalized against the expression of b-actin (three independent analyses). *p < 0.05. (K) Single-cell organoid reconstruction assay of colonic organoids treated by TILF cocktail. Colonic organoids were treated as described in (F), and those TILF-treated tdTomato + organoids were further subjected to single-cell passage. Picture shows organoids at day 5 after second passage from TILF addition (P2; Day5). (L) Single-cell organoid reconstruction assay using colonic IECs isolated from DSS-colitis mice or control mice at day 3. (M) Quantification of organoid reconstruction assay shown in (L), using DSS-colitis mice (n = 3) and control mice (n = 3). Data are expressed as the mean ± SEM. *p < 0.001. See also Figure S5 . 
DISCUSSION
In our lineage-tracing model, the frequency of forming colonic ATOH1 + ICRs reached 250-300 ribbons per mouse under homeostatic conditions and 1,500-1,800 ribbons per mouse in DSS colitis, which certainly exceeded previous models (Tetteh et al., 2016; van Es et al., 2012; Westphalen et al., 2014) . Thus, our results highlight the contribution of ATOH1 + IECs in the maintenance of the ISC pool, particularly in the colon. We also succeeded in Figure S6 . the colon (Shimizu et al., 2014) . Furthermore, an increase of DLL1 + colonic IECs was clearly confirmed in DSS-colitis mice ( Figure 5C ) (Shimizu et al., 2014) . Therefore, the DLL1 + population of ATOH1 + IEC-derived cells may be one of the candidate subpopulations that can form ATOH1 + ICRs in the colon, especially under inflammatory conditions. However, it remains possible that the increase of ATOH1 + ICR formation in DSS-colitis mice depends on the concerted contribution of other unknown subpopulations. A similar de-differentiation has been observed in the airway secretory lineage IECs, suggesting that re-acquiring stem cell properties is inversely related to their maturity (Tata et al., 2013) . Our analysis of ATOH1 + IECs in DSS-colitis mice successfully identified cytokine-or bacterial-component-induced NF-kB activation as a key event in promoting ATOH1 + ICR formation ( Figures 5D-5J ), which is consistent with a previous study involving genetic NF-kB activation in villus IECs (Schwitalla et al., 2013) . Because NF-kB pathway activation in secretory lineage-committed organoids appeared to upregulate the expression of Dll1 ( Figure 5J) , it may be possible that NF-kB signaling promotes ATOH1 + ICR formation via generating an increased number of DLL1 + secretory progenitor cells.
In the AOM-DSS model, ATOH1 + IECs acquired the properties of tumor stem cells and appeared to contribute to the mosaic development of tumors ( Figure 6C ). At present, it remains uncertain to what extent these cells precisely contribute to the overall development and progression of these tumors. The contribution of ATOH1 + tumor cells to the overall tumor formation may be underestimated due to the limited labeling efficiency of the present lineagetracing system. However, the clear mosaic pattern harboring both ATOH1 + and ATOH1 À tumor stem cells may illustrate one of the reasons why colitis-associated tumors are highly resistant to chemotherapeutic approaches. Recently, it has been shown that human colorectal cancer cells can interconvert between differentiated tumor cells and tumor stem cells, thereby exhibiting resistance to tumor stem cell-specific ablation (Shimokawa et al., 2017) . Further studies will be needed to confirm the contribution of ATOH1 + tumor cells to the heterogeneous development and progression of CACs found in IBD patients. Nevertheless, our results newly indicate ATOH1 + tumor cells as an additional therapeutic target cell population for CACs.
EXPERIMENTAL PROCEDURES
Mice C57BL/6J mice and BALB/cAJcl-nu/nu mice were purchased from Japan Clea. mice were provided by RIKEN BRC (Colnot et al., 2004) . The primers used for genotyping are listed in Table S1 . Male and female mice at 8-10 weeks of age were used. All animal experiments were approved by the Animal Care and Use Committee of Tokyo Medical and Dental University (0160326A and 0170276A). For the induction of Cre-mediated recombination, mifepristone (RU486, 2 mg/body, Sigma-Aldrich) or tamoxifen (TMX, 2 mg/body, Sigma-Aldrich) was injected intraperitoneally into mice carrying the Atoh1
Cre-PGR allele or the Lgr5-EGFP-IRES-creERT2 allele, respectively.
Immunohistochemistry
Immunohistochemistry was performed as previously described ). The primary antibodies employed for these assays are listed in Table S2 . Antigen retrieval using citrate buffer was required for the staining of ATOH1, HES1 (Ito et al., 2000) , chromogranin A (CHGA), DCLK1, Ki-67, tdTomato, and b-CATENIN.
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